Gail L Torkildsen MD

Clinical Trials

• Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye Start of enrollment: 2005 Nov 01

  Completed

  Phase 2

• Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model Start of enrollment: 2008 May 01

  Completed

  Phase 4

• Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye Start of enrollment: 2008 Oct 01

  Completed

  Phase 2

• Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye Start of enrollment: 2008 Nov 01

  Completed

  Phase 2

• Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis Start of enrollment: 2009 Feb 01

  Completed

  Phase 2

• Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis Start of enrollment: 2009 Apr 24

  Completed

  Phase 2

• A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE) Start of enrollment: 2009 Aug 03

  Completed

  Phase 2

• A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD Start of enrollment: 2009 Aug 01

  Completed

  Phase 1

• Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry Eye Start of enrollment: 2010 Jun 01

  Completed

  Phase 3

• Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye Start of enrollment: 2010 Nov 01

  Completed

  Phase 2

• Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model Start of enrollment: 2012 Nov 01

  Completed

  Phase 4

• A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers Start of enrollment: 2013 Apr 01

  Completed

  Phase 2

• Safety and Efficacy of PG101 for Dry Eye Syndrome Start of enrollment: 2013 Dec 01

  Completed

  Phase 1, Phase 2

• A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES) Start of enrollment: 2014 Apr 01

  Completed

  Phase 2

• Efficacy and Safety of XG-104 for the Treatment of Dry Eye Start of enrollment: 2014 Sep 01

  Completed

  Phase 2

• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2 Start of enrollment: 2016 Nov 01

  Completed

  Phase 3

• A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes Start of enrollment: 2017 Nov 05

  Completed

  Phase 2

• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3 Start of enrollment: 2019 May 24

  Completed

  Phase 3

• Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution Start of enrollment: 2023 Apr 20

  Completed

  Roles: Contact

• Join now to see all